Can a chromium blend help menopausal women maintain muscle?

NCT ID NCT07402382

Recruiting now Knowledge-focused Sponsor: Nutrition 21, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether an amylopectin chromium blend can improve how the body uses protein and controls blood sugar in women going through or past menopause. Sixty women aged 40-65 will take the supplement or a placebo after a short exercise session. The goal is to see if this simple supplement can support muscle health and metabolic function during midlife.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: amylopectin-chromium blend (dietary supplement)
What this could lead to: If it works, this could point toward a nutritional strategy to support muscle maintenance and metabolic health in midlife women.
What could go wrong: This is a small, early-stage study (60 participants) testing an acute effect, not a long-term treatment. Results may not translate to real-world benefits or generalise beyond this group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLUCOSE MONITORING, CONTINUOUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLUCOSE MONITORING, CONTINUOUS PERI-MENOPAUSAL WOMEN POST-MENOPAUSE WHOLE BODY PROTEIN METABOLISM

Contacts and locations

Locations

The Center for Applied Health Sciences
RECRUITING

Canfield, Ohio, 44406, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.